Page last updated: 2024-08-18

xanthenes and Infarction, Middle Cerebral Artery

xanthenes has been researched along with Infarction, Middle Cerebral Artery in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, W; Ji, X; Liang, J; Liu, KJ; Luo, Y; Qi, Z; Shi, W; Zhao, Y1

Other Studies

1 other study(ies) available for xanthenes and Infarction, Middle Cerebral Artery

ArticleYear
Reduction of zinc accumulation in mitochondria contributes to decreased cerebral ischemic injury by normobaric hyperoxia treatment in an experimental stroke model.
    Experimental neurology, 2015, Volume: 272

    Topics: Analysis of Variance; Animals; Brain; Cholinesterase Inhibitors; Cytochromes c; Disease Models, Animal; Dose-Response Relationship, Drug; Ethylenediamines; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Membrane Potential, Mitochondrial; Mitochondria; Oxygen; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Xanthenes; Zinc

2015